Haleon (LSE:HLN) EV-to-Revenue : 3.42 (As of May. 09, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Haleon's enterprise value is £38,434 Mil. Haleon's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was £11,235 Mil. Therefore, Haleon's EV-to-Revenue for today is 3.42.

The historical rank and industry rank for Haleon's EV-to-Revenue or its related term are showing as below:

LSE:HLN' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.38 Med: 3.14 Max: 4.18
Current: 3.42

During the past 5 years, the highest EV-to-Revenue of Haleon was 4.18. The lowest was 2.38. And the median was 3.14.

LSE:HLN's EV-to-Revenue is ranked worse than
64.04% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs LSE:HLN: 3.42

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-09), Haleon's stock price is £3.282. Haleon's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was £1.22. Therefore, Haleon's PS Ratio for today is 2.70.

Haleon EV-to-Revenue Historical Data

The historical data trend for Haleon's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon EV-to-Revenue Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

3.70

3.39

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial									2.43	3.16	2.55	3.39	2.71

Competitive Comparison of Haleon's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Haleon's EV-to-Revenue falls into.

Haleon EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Haleon's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	38434.212	/	11235
	=	3.42

Haleon's current Enterprise Value is £38,434 Mil.
Haleon's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £11,235 Mil.

Haleon (LSE:HLN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Haleon's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	3.282	/	1.216
	=	2.70

Haleon's share price for today is £3.282.
Haleon's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £1.22.

Haleon EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Haleon's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (LSE:HLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.